The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML
Veronica Novotny‐Diermayr(Biotronik (Singapore)), J M Wood
Cited by 99
Related Papers
Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine
|Scientific Reports|2018|40